Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
SP600125 is an ATP-competitive inhibitor of JNK, with activity against JNK1, JNK2, and JNK3 and also TTK (Mps1), which may lead to cell-cycle inhibition and decreased growth of tumor cells (PMID: 19478553, PMID: 11717429, PMID: 16113653).
|DrugClasses||JNK Inhibitor 4 MPS1 Inhibitor 25|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cetuximab + SP600125||Cetuximab SP600125||1||0|
|Paclitaxel + SP600125||Paclitaxel SP600125||0||0|